within Pharmacolibrary.Drugs.ATC.N;

model N01AX04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00075,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0012,
    k12             = 0.7,
    k21             = 0.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N01AX04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Propanidid is an ultrashort-acting non-barbiturate intravenous anesthetic that was formerly used for the induction of anesthesia. It is no longer approved or used clinically in most countries due to reports of severe anaphylactic reactions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult subjects. No published compartmental PK data are available, so estimates are made based on comparable intravenous anesthetic agents of similar properties.</p><h4>References</h4><ol><li><p>Čižmáriková, R, et al., &amp; Markulia, M (2023). General intravenous anesthetics - pharmacodynamics, pharmacokinetics and chiral properties. <i>Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti</i> 72(4) 155–164. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37805261/\">https://pubmed.ncbi.nlm.nih.gov/37805261</a></p></li><li><p>Ghoneim, MM, &amp; Korttila, K (1977). Pharmacokinetics of intravenous anaesthetics: implications for clinical use. <i>Clinical pharmacokinetics</i> 2(5) 344–372. DOI:<a href=\"https://doi.org/10.2165/00003088-197702050-00003\">10.2165/00003088-197702050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21053/\">https://pubmed.ncbi.nlm.nih.gov/21053</a></p></li><li><p>Frey, HH (1981). [Pharmacokinetics and metabolism of intravenous hypnotic agents (barbiturates, propanidid, etomidate, althesin, ketamine)]. <i>Klinische Anasthesiologie und Intensivtherapie</i> 23 17–29. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7339168/\">https://pubmed.ncbi.nlm.nih.gov/7339168</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N01AX04;
